Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Federal Trade Commission
Fish and Richardson
Express Scripts
Daiichi Sankyo
US Department of Justice
Citi
Chubb
Cerilliant

Generated: April 21, 2018

DrugPatentWatch Database Preview

IDAMYCIN Drug Profile

« Back to Dashboard

Which patents cover Idamycin, and when can generic versions of Idamycin launch?

Idamycin is a drug marketed by Pharmacia And Upjohn and is included in two NDAs.

The generic ingredient in IDAMYCIN is idarubicin hydrochloride. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the idarubicin hydrochloride profile page.
Drug patent expirations by year for IDAMYCIN
Medical Subject Heading (MeSH) Categories for IDAMYCIN
Synonyms for IDAMYCIN
(1S,3S)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydronaphthacen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside
(1s,3s)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-|A-l-lyxo-hexopyranoside
(1s,3s)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-A-l-lyxo-hexopyranoside
(1S,3S)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside
(7S-cis)-9-Acetyl-7-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione
(7S,9S)-7-[(2R,4S,5S,6S)-4-azanyl-6-methyl-5-oxidanyl-oxan-2-yl]oxy-9-ethanoyl-6,9,11-tris(oxidanyl)-8,10-dihydro-7H-tetracene-5,12-dione
(7S,9S)-7-[(2R,4S,5S,6S)-4-azanyl-6-methyl-5-oxidanyl-oxan-2-yl]oxy-9-ethanoyl-6,9,11-tris(oxidanyl)-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione
(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-quinone;hydrochloride
(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione
(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
(7S,9S)-9-acetyl-7-[[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione
(7S,9S)-9-acetyl-7-[[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
(7S,9S)-9-acetyl-7-{[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,9,11-trihydroxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione
15158-EP2270008A1
15158-EP2272827A1
15158-EP2275420A1
15158-EP2277879A1
15158-EP2280012A2
15158-EP2281815A1
15158-EP2289892A1
15158-EP2292615A1
15158-EP2292617A1
15158-EP2295055A2
15158-EP2295416A2
15158-EP2295426A1
15158-EP2295427A1
15158-EP2298748A2
15158-EP2298764A1
15158-EP2298765A1
15158-EP2301928A1
15158-EP2301933A1
15158-EP2305640A2
15158-EP2305642A2
15158-EP2305671A1
15158-EP2308833A2
15158-EP2308855A1
15158-EP2311453A1
15158-EP2311808A1
15158-EP2311825A1
15158-EP2311827A1
15158-EP2311829A1
15158-EP2311842A2
15158-EP2316832A1
15158-EP2316833A1
4-Demethoxydaunomycin
4-Demethoxydaunorubicin
4-Demethoxydaunorubicin|||IMI-30|||NSC-256439|||(7S,9S)-9-Acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione
4-Desmethoxydaunorubicin
4-DMD
5,12-Naphthacenedione, 7,8,9,10-tetrahydro-9-acetyl-7-((3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy)-6,9,11-trihydroxy-, (7S-cis)-
5,12-Naphthacenedione, 7,8,9,10-tetrahydro-9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-6,9,11-trihydroxy-, (7S-cis)-
5,12-Naphthacenedione, 9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, (7S-cis)-
57852-57-0
57852-57-0 (HYDROCHLORIDE)
58957-92-9
957I929
A832088
AB00698511_11
AB00698511-06
AB00698511-08
AB00698511-09
AB00698511-10
AC-9384
AC1L28SA
AC1Q6JJ4
AKOS015895563
AN-11145
API0002970
BCP9000773
BCPP000207
BDBM58490
BRD-K69650333-001-01-1
C-22925
C26H27NO9
CC-29462
CCG-204689
CCRIS 5083
CHEBI:42068
CHEMBL1117
cid_636362
D01XDL
D08062
Daunomycin, 4-demethoxy-
DB01177
demethoxydaunorubicin
DM5
DMDR
DTXSID7023142
EU-0100600
FT-0621481
GTPL7083
HMS2089D05
HMS3261H22
I 1656
I06-1097
Idamycin (TN)
Idamycin PFS
IDARUBICIN
Idarubicin (INN)
Idarubicin [INN:BAN]
Idarubicin Hcl
Idarubicin Hcl Pfs
idarubicin hydrochloride
Idarubicin hydrochloride, solid
Idarubicin, United States Pharmacopeia (USP) Reference Standard
IDARUBICIN(Hydrochloride form)
Idarubicina
Idarubicina [INN-Spanish]
Idarubicine
Idarubicine [INN-French]
Idarubicinum
Idarubicinum [INN-Latin]
IMI 30
IMI-30
KBioSS_002388
Lopac0_000600
LP00600
LS-94015
MLS001401448
MolPort-006-167-730
NCGC00093976-01
NCGC00093976-02
NCGC00093976-03
NCGC00093976-04
NCGC00093976-05
NCGC00261285-01
NSC-256439
PL046679
SC-17016
SCHEMBL3750
SMR000466355
SR-01000075934
SR-01000075934-1
Tox21_500600
UNII-ZRP63D75JW
XDXDZDZNSLXDNA-TZNDIEGXSA-N
Z-3092
Zavedos
Zavedos (TN)
ZINC3920266
ZRP63D75JW

US Patents and Regulatory Information for IDAMYCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn IDAMYCIN idarubicin hydrochloride INJECTABLE;INJECTION 050661-002 Sep 27, 1990 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn IDAMYCIN PFS idarubicin hydrochloride INJECTABLE;INJECTION 050734-001 Feb 17, 1997 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn IDAMYCIN idarubicin hydrochloride INJECTABLE;INJECTION 050661-001 Sep 27, 1990 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn IDAMYCIN idarubicin hydrochloride INJECTABLE;INJECTION 050661-003 Apr 25, 1995 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Moodys
US Army
Julphar
Accenture
Cipla
QuintilesIMS
Dow
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.